Becton Dickinson and Co

More Details of Becton Dickinson and Co Company

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Company Info

Company codeBDX

Company nameBecton Dickinson and Co

IPO dateSep 25, 1963

Founded at1906

CEOMr. Thomas E. Polen

Number of employees74000

Security typeOrdinary Share

Fiscal year-endSep 25

AddressOne Becton Drive

CityFRANKLIN LAKES

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code07417-1880

Phone12018476800

Websitehttps://www.bd.com/

Company codeBDX

IPO dateSep 25, 1963

Founded at1906

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Richard (Rick) Byrd

Executive Vice President, President - Interventional Segment

754.64K

-0.32%

Mr. Timothy M. (Tim) Ring

Independent Director

59.87K

+1.58%

Ms. Shana Carol Neal

Chief People Officer, Executive Vice President

47.02K

-3.86%

Ms. Catherine M. (Cathy) Burzik

Independent Director

14.81K

+6.70%

Mr. Roland Goette

Executive Vice President, President - EMEA

14.21K

-8.25%

Mr. Antoine C. Ezell

Executive Vice President, President, North America, Chief Marketing Officer

11.97K

+28.43%

Mr. Michael Feld

Executive Vice President, President - Life Sciences

9.19K

+38.45%

Mr. Robert Andrew (Andy) Eckert

Independent Director

9.14K

+11.33%

Ms. Michelle Quinn

Executive Vice President, General Counsel

6.93K

+39.80%

Dr. Carrie L. Byington, M.D.

Independent Director

5.25K

+21.54%

Name

Name/Position

Position

Shareholding

Change

Mr. Richard (Rick) Byrd

Executive Vice President, President - Interventional Segment

754.64K

-0.32%

Mr. Timothy M. (Tim) Ring

Independent Director

59.87K

+1.58%

Ms. Shana Carol Neal

Chief People Officer, Executive Vice President

47.02K

-3.86%

Ms. Catherine M. (Cathy) Burzik

Independent Director

14.81K

+6.70%

Mr. Roland Goette

Executive Vice President, President - EMEA

14.21K

-8.25%

Mr. Antoine C. Ezell

Executive Vice President, President, North America, Chief Marketing Officer

11.97K

+28.43%

Revenue Breakdown

Currency: USDUpdate time: Sun, Apr 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Medication Delivery Solutions

1.12B

21.75%

Medication Management Solutions

801.00M

15.50%

Integrated Diagnostic Solutions

474.00M

9.17%

Peripheral Intervention

473.00M

9.15%

Specimen Management

462.00M

8.94%

Other

1.83B

35.49%

By RegionUSD

Name

Revenue

Proportion

United States

3.08B

59.58%

International

2.09B

40.42%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Medication Delivery Solutions

1.12B

21.75%

Medication Management Solutions

801.00M

15.50%

Integrated Diagnostic Solutions

474.00M

9.17%

Peripheral Intervention

473.00M

9.15%

Specimen Management

462.00M

8.94%

Other

1.83B

35.49%

Shareholder

Update time: Sat, Apr 26

Shareholder Statistics

Type

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.27%

BlackRock Institutional Trust Company, N.A.

5.16%

State Street Global Advisors (US)

4.91%

T. Rowe Price Investment Management, Inc.

4.22%

T. Rowe Price Associates, Inc.

4.15%

Other

72.29%

Shareholder Statistics

Shareholder

Proportion

The Vanguard Group, Inc.

9.27%

BlackRock Institutional Trust Company, N.A.

5.16%

State Street Global Advisors (US)

4.91%

T. Rowe Price Investment Management, Inc.

4.22%

T. Rowe Price Associates, Inc.

4.15%

Other

72.29%

Type

Shareholder

Proportion

Investment Advisor

41.45%

Investment Advisor/Hedge Fund

40.99%

Pension Fund

2.83%

Hedge Fund

2.51%

Research Firm

2.37%

Bank and Trust

1.64%

Sovereign Wealth Fund

1.23%

Individual Investor

0.57%

Insurance Company

0.28%

Other

6.12%

Institutional Shareholding

Update time: Sun, Jan 19

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

2842

271.04M

94.39%

-4.33M

2024Q4

2874

271.53M

94.56%

-4.62M

2024Q3

2787

266.29M

92.14%

-3.20M

2024Q2

2782

261.01M

90.31%

-2.68M

2024Q1

2797

255.99M

88.58%

-10.13M

2023Q4

2783

259.38M

89.78%

-7.79M

2023Q3

2768

264.64M

91.23%

-591.87K

2023Q2

2787

263.29M

90.78%

-570.64K

2023Q1

2795

257.22M

90.56%

-8.75M

2022Q4

2831

255.72M

90.07%

-14.76M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

26.61M

9.27%

+188.34K

+0.71%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

14.81M

5.16%

+196.28K

+1.34%

Dec 31, 2024

State Street Global Advisors (US)

14.09M

4.91%

+134.36K

+0.96%

Dec 31, 2024

T. Rowe Price Investment Management, Inc.

12.13M

4.22%

+3.22M

+36.14%

Dec 31, 2024

T. Rowe Price Associates, Inc.

11.93M

4.15%

-1.16M

-8.84%

Dec 31, 2024

Geode Capital Management, L.L.C.

6.35M

2.21%

+66.02K

+1.05%

Dec 31, 2024

Generation Investment Management LLP

5.82M

2.03%

-139.25K

-2.34%

Dec 31, 2024

Morgan Stanley Investment Management Ltd. (UK)

5.70M

1.98%

-310.28K

-5.16%

Dec 31, 2024

MFS Investment Management

5.45M

1.9%

+708.73K

+14.93%

Dec 31, 2024

First Eagle Investment Management, L.L.C.

4.43M

1.54%

+1.06M

+31.36%

Dec 31, 2024

Related ETFs

Update time: Sun, Apr 6

Name

Proportion

iShares U.S. Medical Devices ETF

4.18%

Natixis Vaughan Nelson Select ETF

4.12%

ClearBridge Dividend Strategy ESG ETF

3.3%

T Rowe Price Capital Appreciation Equity ETF

2.93%

First Eagle Global Equity ETF

2.82%

American Century Focused Large Cap Value ETF

2.61%

Touchstone US Large Cap Focused ETF

1.86%

ProShares MSCI Transformational Changes ETF

1.84%

T Rowe Price Equity Income ETF

1.76%

Running Oak Efficient Growth ETF

1.73%

iShares U.S. Medical Devices ETF

Proportion4.18%

Natixis Vaughan Nelson Select ETF

Proportion4.12%

ClearBridge Dividend Strategy ESG ETF

Proportion3.3%

T Rowe Price Capital Appreciation Equity ETF

Proportion2.93%

First Eagle Global Equity ETF

Proportion2.82%

American Century Focused Large Cap Value ETF

Proportion2.61%

Touchstone US Large Cap Focused ETF

Proportion1.86%

ProShares MSCI Transformational Changes ETF

Proportion1.84%

T Rowe Price Equity Income ETF

Proportion1.76%

Running Oak Efficient Growth ETF

Proportion1.73%

Dividend

A total of 5.34B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 28, 2025

BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025

Mar 10, 2025

Mar 31, 2025

Mar 10, 2025

Nov 07, 2024

BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024

Dec 09, 2024

Dec 31, 2024

Dec 09, 2024

Jul 23, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024

Sep 09, 2024

Sep 30, 2024

Sep 09, 2024

Apr 30, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024

Jun 10, 2024

Jun 28, 2024

Jun 10, 2024

Jan 23, 2024

BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024

Mar 08, 2024

Mar 29, 2024

Mar 07, 2024

Nov 09, 2023

BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023

Dec 08, 2023

Dec 29, 2023

Dec 07, 2023

Jul 25, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023

Sep 08, 2023

Sep 29, 2023

Sep 07, 2023

Apr 25, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023

Jun 09, 2023

Jun 30, 2023

Jun 08, 2023

Jan 24, 2023

BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023

Mar 10, 2023

Mar 31, 2023

Mar 09, 2023

Nov 10, 2022

BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022

Dec 09, 2022

Dec 30, 2022

Dec 08, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

184.600USD

Becton Dickinson and Co

184.600

Overview

Company